Sensex, Nifty Snap Three-Day Losing Streak In May F&O Expiry Day

The Midcap index outperformed Sensex and Nifty while the Smallcap measure underperformed its larger peers. Barring the fmcg index, all the other 18 sectoral indices compiled by BSE Ltd. advanced with S&P BSE Metal adding over 3.3%.

The market breadth was skewed in the favour of bulls. About 1,779 stocks advanced, 1,520 declined and 130 remained unchanged.

Q4FY2021-22 (Consolidated, YoY)

• Net income up 65% at Rs 190.52 crore Vs Rs 115.56 crore (Bloomberg consensus estimate: Rs 149 crore)

• Revenue up 26% at Rs 1,111.11 crore Vs Rs 880.77 crore (Estimate: Rs 1,061.72 crore)

• Ebitda up 57% at Rs 267.09 crore Vs Rs 169.81 crore (Estimate: Rs 217 crore)

• Ebitda margin at 24% Vs 19.30%

• Company approved a fourth interim dividend for FY2021-22 of Rs 70 per equity share.

• The record date fixed for payment of interim dividend is June 3, 2022. The date fixed for payment of dividend is on or before June 24, 2022.

Source: Exchange filing

Thermal power plant developer RattanIndia Enterprises buys 60% stake in leading domestic drone maker Throttle Aerospace Systems Pvt. This investment has been done through NeoSky India, a subsidiary of RattanIndia Enterprises.

• The company said it will target global markets for its drone products and services and reiterated plans to acquire best intellectual capital and technology available in the drone sector.

• With this acquisition NeoSky will be able to provide full 360 degree drone solutions to customers with Drones as a Product, Drone as a Service and Software as a Service.

Source: Exchange filing

HCL Technologies has signed an end-to-end global digital transformation deal with Velux Group.

• Velux group is a leading Danish maker of roof windows.

• HCL Tech will deliver a cloud-first, user-centric digital transformation program for the Velux group to modernise its applications and infrastructure landscape.

Source: Exchange filing

Davos WEF 2022 | Kumar Mangalam Birla Sees Headroom To Invest In New Businesses Alongside $10-Billion Plan

Torrent Pharma Shares Jump Most In A Year As Analysts See Better Margin, Domestic Growth In FY23

The Sensex lost 0.30% to 53,590.47. The Nifty declined by similar magnitude to 15,970.75.

The MidCap index outperformed its larger peers while the SmallCap index mirrored Sensex and Nifty. Twelve of the 19 sectoral indices compiled by BSE Ltd. declined with power and utilities indices falling the most. On the flipside, metal index added 2%.

The market breadth was skewed in the favour of bears. About 1,079 stocks advanced, 2,120 declined and 120 remained unchanged.

The top court bench has allowed the appeal by SFIO challenging the stay on the look out circular and the investigation against few Sahara group companies

The SFIO had appealed the stay granted by the Delhi High Court.

The IPO was subscribed 0.52 times or 52% as of 11:00 a.m. on May 26.

• Institutional Investors: 0.39 times.

• Non-institutional investors: 0.18 times.

• Retail investors: 0.72 times.

• Employees: 0.94 times.

Aurobindo Pharma's subsidiary Eugia Pharma received final approval from U.S. FDA to manufacture and market Pemetrexed for injection, 100 mg, 500 mg and 1000 mg.

• The product will be launched immediately and is therapeutically equivalent to the RLD, Alimta for injetion, of Eli Lilly.

• The injection is indicated for treatment of antineoplastics (medications used to treat cancer).

• The drug has an estimated market size of $1,272 million for 12 mnths ended March 2022, according to IQVIA.

Source: Exchange Filing

The S&P BSE Sensex rose 0.5% to 53,999.81. The Nifty 50 advanced by similar magnitude to 16,093.65.

The broader indices almost mirrored their larger peers. Fifteen of the 19 sectoral indices compiled by BSE Ltd. advanced with S&P BSE Metal gaining 1.4%.

The market breadth was skewed in the favour of bulls. About 1,238 stocks advanced, 877 declined and 84 remained unchanged.

• Hindalco Industries

• Zee Entertainment

• Berger Paints

• Piramal Enterprises

• Quess Corp

• Motherson Sumi Systems

• Page Industries

• Muthoot Finance

• NMDC

• Motherson Sumi Wiring India

• Colgate Palmolive

• Bharat Dynamics

• Bharat Rasayan

• Cummins

• INEOS Styrolution India

• Insecticides India

• India Glycols

• Kirloskar Industries

• Tata Steel: The company acquired 3.55 lakh shares of Rs 10 each of wholly owned subsidiary Tata Steel Downstream Products at a premium of Rs 130.5 per share.

• Vodafone Idea: The Government of India has received exemption from open offer to acquire 33.4% stake in the telecom company.

• Aegis: Aegis Vopak terminals were successfully completed making it the largest independent tank storage company for LPG and chemicals in India.

• Infosys: The company will collaborate with Palo Alto Networks to elevate the security-maturity of large enterprises and to help prevent the threat of cyberattacks on their critical infrastructure.

BPCL Q4 FY22 (Consolidated, YoY)

• Revenue up 24% at Rs 1,23,217 crore

• EBITDA down 6% at Rs 5,954 crore

• EBITDA margin at 4.8% vs 6.3%

• Net profit down 73% at Rs 2,803 crore

• Recommended final dividend of Rs 6 per share

Coal India Q4 FY22 (Consolidated, YoY)

• Revenue up 22.5% at Rs 32,706.77 crore

• EBITDA up 41% at Rs 9,078.82 crore

• EBITDA margin at 27.76% Vs 24.11%

• Net profit up 46% at Rs 6,692.94 crore

• Recommended final dividend of Rs 3 per share

Nalco Q4 FY22 (Standalone, YoY)

• Revenue up 53.85% at Rs 4,340.82 crore

• EBITDA up 71.46% at Rs 1,618.59 crore

• EBITDA margin at 37.3% Vs 33.46%

• Net profit up 9.6% at Rs 1,025.68 crore

Apollo Hospitals Enterprises Q4 FY22 (Consolidated, YoY)

• Revenue up 24% at Rs 3,546 crore

• Net profit down 46% at Rs 90 crore

• EBITDA up 12% at Rs 463 crore

• Margins at 13.1% vs 14.4%

• Net profit down 46% to Rs 90 crore

InterGlobe Aviation Q4 FY22 (Standalone, YoY)

• Revenue up 29% at Rs 8,021 crore

• EBITDAR at Rs 172 crore vs Rs 648 crore

• EBITDAR margin at 2.1% vs 10.4%

• Net Loss of Rs 1,680 crore vs Rs 1,159 crore loss

Whirlpool of India Q4 FY22 (Standalone, YoY)

• Revenue down 9.5% at Rs 1610.63 crore

• EBITDA down 28.37% at Rs 135.84 crore

• EBITDA margin at 8.43% vs 10.66%

• Net profit down 35.7% at Rs 79.53 crore

• Recommended final dividend of Rs 5 per share

Torrent Pharma Q4 FY22 (Consolidated, YoY)

• Revenue up 10% at Rs 2,131 crore

• EBITDA down 4% at Rs 561 crore

• EBITDA margin at 26.3% vs 30%

• Net loss at Rs 118 crore vs net profit of Rs 324 crore

• Recommended final dividend of Rs 23/share

• Approved issue of bonus shares in the ratio of 1:1

Bata India Q4 FY22 (Consolidated, YoY)

• Revenue up 13% at Rs 665 crore

• EBITDA up 44% at Rs 162 crore

• EBITDA margin at 24.4% vs 19%

• Net profit up 114% at Rs 63 crore

• Recommended dividend of Rs 54.5 per share

Fortis Healthcare Q4 FY22 (Consolidated, YoY)

• Revenue up 10% at Rs 1,378 crore

• EBITDA up 12% at Rs 221 crore

• EBITDA margin at 16.1% vs 15.8%

• Net profit up 40% at Rs 87 crore

Religare Enterprises Q4 FY22 (Consolidated, QoQ)

• Revenue up 15% at Rs 953 crore

• Net loss at Rs 588 crore vs Rs 251 crore

• EBIT profit at Rs 114 crore vs loss of Rs 108 crore

• EBIT margin at 12% Vs -13%

Stock Market Today: All You Need To Know Going Into Trade On May 26